Table 1.
Baseline characteristics of the study population*.
Index |
Group A (n = 100) |
Group B (n = 100) |
P value |
---|---|---|---|
Mean age (years) | 37.83 ± 2.09 | 37.81 ± 1.79 | 0.431 |
BMI (kg/m2)y | 24.03 ± 2.84 | 24.08 ± 2.96 | 0.969 |
Infertility duration (years) | 4.04 ± 3.11 | 4.03 ± 2.74 | 0.095 |
Primary infertility (%) | 37 (21) | 35 (22) | 0.883 |
Basal FSH (IU/L) | 7.90 ± 1.60 | 7.45 ± 1.71 | 0.082 |
Basal LH (IU/L) | 5.71 ± 5.21 | 5.11 ± 4.17 | 0.551 |
Basal E2 (pg/mL) | 39.37 ± 11.92 | 40.10 ± 14.41 | 0.898 |
Basal T (ng/dL) | 20.86 ± 10.33 | 21.42 ± 12.38 | 0.593 |
AMH (ng/mL) | 1.93 ± 1.17 | 2.20 ± 1.08 | 0.432 |
TSH (uIU/ml) | 2.14 ± 0.91 | 2.03 ± 0.92 | 0.576 |
Antral follicle count | 9.77 ± 4.11 | 10.71 ± 4.29 | 0.455 |
Proportion of IVF (%) | 74 (74) | 74 (74) | 1.000 |
Proportion of ICSI (%) | 26 (2) | 26 (2) | 1.000 |
Plus-minus values can be indicated by means ± SD. No significant intergroup differences existed in baseline characteristics (p > 0.05). FSH, follicle-stimulating hormone; LH, luteinising hormone; T, total testosterone; E2, oestradiol; AMH, anti-Müllerian hormone; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection.
BMI, body mass index can be calculated as the weight (kilograms) divided by the square of height (meters).
Data are number/total number or number (%) unless stated otherwise.